SCHEMBL30543778

SCHEMBL30543778

NC(=O)c1ncn([C@@H]2O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]2O)c1N/C=N\[C@@H]1O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]1O

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATIC P31939 3/20 0.77
FBP1 P09467 2/20 0.65
TAS1R3 Q7RTX0 5/20 0.49
TAS1R1 Q7RTX1 5/20 0.49
DNPH1 O43598 3/20 0.49
LDHA P00338 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
PRKAB2 O43741 1/20 0.49
TRPM2 O94759 1/20 0.49
ADRB2 P07550 1/20 0.49
SRC P12931 1/20 0.49
ADORA1 P30542 1/20 0.49
P2RY2 P41231 1/20 0.49
P2RY1 P47900 1/20 0.49
PRKAG1 P54619 1/20 0.49
PRKAA2 P54646 1/20 0.49
PDE4D Q08499 1/20 0.49
KCNH2 Q12809 1/20 0.49
PRKAA1 Q13131 1/20 0.49
PDE3A Q14432 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Faicar SCHEMBL851406 0.87 ATIC (1.00) ATICFBP1TAS1R3TAS1R1DNPH1
Faicar SCHEMBL4360247 0.87 ATIC (1.00) ATICFBP1TAS1R3TAS1R1DNPH1
SCHEMBL30388429 0.81 ATIC (0.67) ATICFBP1TAS1R3TAS1R1DNPH1
SCHEMBL20276955 0.79 ATIC (1.00) ATICFBP1TAS1R3TAS1R1DNPH1
Mizoribine Monophosphate SCHEMBL12727826 0.79 ATIC (0.80) ATICFBP1TAS1R3TAS1R1DNPH1
SCHEMBL849848 0.79 ATIC (1.00) ATICFBP1TAS1R3TAS1R1DNPH1
SCHEMBL1230585 0.79 ATIC (1.00) ATICFBP1TAS1R3TAS1R1DNPH1
SCHEMBL4359472 0.79 ATIC (1.00) ATICFBP1TAS1R3TAS1R1DNPH1
Mizoribine Monophosphate SCHEMBL16329889 0.79 ATIC (0.80) ATICFBP1TAS1R3TAS1R1DNPH1
SCHEMBL20134003 0.79 ATIC (1.00) ATICFBP1TAS1R3TAS1R1DNPH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119220474-B Escherichia coli genetically engineered bacterium for producing L-histidine through fermentation, method and application 天津科技大学 2025-02-25 CN claimed
CN-119220474-A Escherichia coli genetically engineered bacterium for producing L-histidine through fermentation, method and application 天津科技大学 2024-12-31 CN claimed
US-20240124907-A1 Engineered Biosynthetic Pathways for Production of Histamine by Fermentation ZYMERGEN INC. (US) 2024-04-18 US claimed
US-11739355-B2 Engineered biosynthetic pathways for production of histamine by fermentation ZYMERGEN INC. (US) 2023-08-29 US claimed
CN-119220474-B Escherichia coli genetically engineered bacterium for producing L-histidine through fermentation, method and application 天津科技大学 2025-02-25 CN disclosed
CN-119220474-A Escherichia coli genetically engineered bacterium for producing L-histidine through fermentation, method and application 天津科技大学 2024-12-31 CN disclosed
US-20240124907-A1 Engineered Biosynthetic Pathways for Production of Histamine by Fermentation ZYMERGEN INC. (US) 2024-04-18 US disclosed
US-11739355-B2 Engineered biosynthetic pathways for production of histamine by fermentation ZYMERGEN INC. (US) 2023-08-29 US disclosed